Given that IGFBP3 is a secretary protein, we considered whether IGFBP3 protein could be measured in the plasma of OSCC patients and used to differentiate the status of lymph node metastasis. The gene discussed is IGFBP3; the disease is metastatic malignant neoplasm in the lymph nodes.